ArticleAsian Pacific journal of cancer prevention : APJCP2017

The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial

Georg Holgersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.